# OnCo record fmc-376 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/fmc-376/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "fmc-376" ;
  schema:name "FMC-376"@en ;
  schema:description "FMC-376 is an experimental oral covalent small molecule from Frontier Medicines, in phase 1 trials for KRAS G12C-mutated solid tumours and non-small cell lung cancer."@en ;
  schema:url <https://onco.cc/drugs/fmc-376/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.frontiermeds.com/precision-pipeline/KRAS-GTP>, <https://clinicaltrials.gov/api/v2/studies/NCT06244771>, <https://clinicaltrials.gov/search?intr=FMC-376> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral covalent small molecule" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:companies <https://onco.cc/companies/frontier-medicines/> ;
  onco:trials <https://onco.cc/trials/nct06244771/> .